The DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.
Indole-3-Acetic Acid Alleviates Nonalcoholic Fatty Liver Disease in Mice via Attenuation of Hepatic Lipogenesis, and Oxidative and Inflammatory Stress
Open accessAbstract
Recent evidences have linked indole-3-acetic acid (IAA), a gut microbiota-derived metabolite from dietary tryptophan, with the resistance to liver diseases. However, data supporting IAA-mediated protection against nonalcoholic fatty liver disease (NAFLD) from an in vivo study is lacking. In this study, we assessed the role of IAA in attenuating high-fat diet (HFD)-induced NAFLD in male C57BL/6 mice. Administration of IAA (50 mg/kg body weight) by intraperitoneal injection was found to alleviate HFD-induced elevation in fasting blood glucose and homeostasis model assessment of insulin resistance (HOMA-IR) index as well as plasma total cholesterol, low-density lipoprotein cholesterol (LDL-C), and glutamic-pyruvic transaminase (GPT) activity. Histological examination further presented the protective effect of IAA on liver damage induced by HFD feeding. HFD-induced an increase in liver total triglycerides and cholesterol, together with the upregulation of genes related to lipogenesis including sterol regulatory element binding-protein 1 (Srebf1), steraroyl coenzyme decarboxylase 1 (Scd1), peroxisome proliferator-activated receptor gamma (PPARγ), acetyl-CoA carboxylase 1 (Acaca), and glycerol-3-phosphate acyltransferase, mitochondrial (Gpam), which were mitigated by IAA treatment. The results of reactive oxygen species (ROS) and malonaldehyde (MDA) level along with superoxide dismutase (SOD) activity and glutathione (GSH) content in liver tissue evidenced the protection of IAA against HFD-induced oxidative stress. Additionally, IAA attenuated the inflammatory response of liver in mice exposed to HFD as shown by the reduction in the F4/80-positive macrophage infiltration and the expression of monocyte chemoattractant protein-1 (MCP-1) and tumor necrosis factor-α (TNF-α). In conclusion, our findings uncover that IAA alleviates HFD-induced hepatotoxicity in mice, which proves to be associated with the amelioration in insulin resistance, lipid metabolism, and oxidative and inflammatory stress.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention
Younossi, Z., Anstee, Q. M., Marietti, M., Hardy, T., Henry, L., Eslam, M., George, J., & Bugianesi, E. (2018) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2017.109 · Cited by 5,249
Monocyte Chemoattractant Protein-1 (MCP-1): An Overview
Deshmane, S. L., Kremlev, S., Amini, S., & Sawaya, B. E. (2009) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.2008.0027 · Cited by 3,889
The multiple-hit pathogenesis of non-alcoholic fatty liver disease (NAFLD)
Buzzetti, E., Pinzani, M., & Tsochatzis, E. A. (2016) · Metabolism · doi:10.1016/j.metabol.2015.12.012 · Cited by 3,119
Microbial tryptophan catabolites in health and disease
Roager, H. M., & Licht, T. R. (2018) · Nature Communications · doi:10.1038/s41467-018-05470-4 · Cited by 2,236
Molecular mechanisms of hepatic lipid accumulation in non-alcoholic fatty liver disease
Ipsen, D. H., Lykkesfeldt, J., & Tveden-Nyborg, P. (2018) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-018-2860-6 · Cited by 1,471
The role of macrophages in nonalcoholic fatty liver disease and nonalcoholic steatohepatitis
Kazankov, K., Jørgensen, S. M. D., Thomsen, K. L., Møller, H. J., Vilstrup, H., George, J., Schuppan, D., & Grønbæk, H. (2019) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-018-0082-x · Cited by 941
Serum activity of alanine aminotransferase (ALT) as an indicator of health and disease†
Kim, W. R., Flamm, S. L., Di Bisceglie, A. M., & Bodenheimer, H. C. (2008) · Hepatology · doi:10.1002/hep.22109 · Cited by 857
Krishnan, S., Ding, Y., Saedi, N., Choi, M., Sridharan, G. V., Sherr, D. H., Yarmush, M. L., Alaniz, R. C., Jayaraman, A., & Lee, K. (2018) · Cell Reports · doi:10.1016/j.celrep.2018.03.109 · Cited by 679
Role of Oxidative Stress in Pathophysiology of Nonalcoholic Fatty Liver Disease
Masarone, M., Rosato, V., Dallio, M., Gravina, A. G., Aglitti, A., Loguercio, C., Federico, A., & Persico, M. (2018) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2018/9547613 · Cited by 648
Natividad, J. M., Agus, A., Planchais, J., Lamas, B., Jarry, A. C., Martin, R., Michel, M.-L., Chong-Nguyen, C., Roussel, R., Straube, M., et al. (2018) · Cell Metabolism · doi:10.1016/j.cmet.2018.07.001 · Cited by 642
Indole and Tryptophan Metabolism: Endogenous and Dietary Routes to Ah Receptor Activation
Hubbard, T. D., Murray, I. A., & Perdew, G. H. (2015) · Drug Metabolism and Disposition · doi:10.1124/dmd.115.064246 · Cited by 640
Uncovering the trimethylamine-producing bacteria of the human gut microbiota
Rath, S., Heidrich, B., Pieper, D. H., & Vital, M. (2017) · Microbiome · doi:10.1186/s40168-017-0271-9 · Cited by 515
Histopathology of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis
Takahashi, Y. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i42.15539 · Cited by 486
Hepatic Lipid Partitioning and Liver Damage in Nonalcoholic Fatty Liver Disease
Li, Z. Z., Berk, M., McIntyre, T. M., & Feldstein, A. E. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m807616200 · Cited by 400
Oxidative Stress as a Critical Factor in Nonalcoholic Fatty Liver Disease Pathogenesis
Spahis, S., Delvin, E., Borys, J.-M., & Levy, E. (2017) · Antioxidants & Redox Signaling · doi:10.1089/ars.2016.6776 · Cited by 386
Non-alcoholic fatty liver disease: The diagnosis and management
El-Kader, S. M. A. (2015) · World Journal of Hepatology · doi:10.4254/wjh.v7.i6.846 · Cited by 381
Fang, Y.-L., Chen, H., Wang, C.-L., & Liang, L. (2018) · World Journal of Gastroenterology · doi:10.3748/wjg.v24.i27.2974 · Cited by 379
Self-citationInsights into the Role and Interdependence of Oxidative Stress and Inflammation in Liver Diseases
Li, S., Hong, M., Tan, H.-Y., Wang, N., & Feng, Y. (2016) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2016/4234061 · Cited by 368
Hendrikx, T., Duan, Y., Wang, Y., Oh, J.-H., Alexander, L. M., Huang, W., Stärkel, P., Ho, S. B., Gao, B., Fiehn, O., et al. (2019) · Gut · doi:10.1136/gutjnl-2018-317232 · Cited by 361
Role of inflammatory response in liver diseases: Therapeutic strategies
Campo, J. A. D., Gallego, P., & Grande, L. (2018) · World Journal of Hepatology · doi:10.4254/wjh.v10.i1.1 · Cited by 348
Rau, M., Schilling, A.-K., Meertens, J., Hering, I., Weiss, J., Jurowich, C., Kudlich, T., Hermanns, H. M., Bantel, H., Beyersdorf, N., et al. (2016) · The Journal of Immunology · doi:10.4049/jimmunol.1501175 · Cited by 302
Ji, Y., Yin, Y., Li, Z., & Zhang, W. (2019) · Nutrients · doi:10.3390/nu11081712 · Cited by 230
Self-citationPolimeni, L. (2015) · World Journal of Hepatology · doi:10.4254/wjh.v7.i10.1325 · Cited by 202
Kakino, S., Ohki, T., Nakayama, H., Yuan, X., Otabe, S., Hashinaga, T., Wada, N., Kurita, Y., Tanaka, K., Hara, K., et al. (2017) · Hormone and Metabolic Research · doi:10.1055/s-0043-118666 · Cited by 151
Role of bioactive fatty acids in nonalcoholic fatty liver disease
Juárez-Hernández, E., Chávez-Tapia, N. C., Uribe, M., & Barbero-Becerra, V. J. (2015) · Nutrition Journal · doi:10.1186/s12937-016-0191-8 · Cited by 147
Surrogate measures of insulin resistance: of rats, mice, and men
Mather, K. J. (2009) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.90889.2008 · Cited by 134
Wang, L.-F., Wang, X., Huang, C., Hu, L. H., Xiao, Y., Guan, X., Qian, Y., Deng, K., & Xin, H. (2017) · Lipids in Health and Disease · doi:10.1186/s12944-017-0464-z · Cited by 124
Fatty liver diseases, bile acids, and FXR
Zhu, Y., Liu, H., Zhang, M., & Guo, G. L. (2016) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2016.07.008 · Cited by 122
Role of the Ah Receptor in Homeostatic Control of Fatty Acid Synthesis in the Liver
Tanos, R., Murray, I. A., Smith, P. B. W., Patterson, A. D., & Perdew, G. H. (2012) · Toxicological Sciences · doi:10.1093/toxsci/kfs204 · Cited by 89
The role of hepatic macrophages in nonalcoholic fatty liver disease and nonalcoholic steatohepatitis
Cha, J.-Y., Kim, D.-H., & Chun, K. (2018) · Laboratory Animal Research · doi:10.5625/lar.2018.34.4.133 · Cited by 78
Indole-3-carbinol as a scavenger of free radicals
Arnao, M. B., Sánchez‐Bravo, J., & Acosta, M. (1996) · IUBMB Life · doi:10.1080/15216549600201302 · Cited by 76
Genetic and hormonal control of hepatic steatosis in female and male mice
Norheim, F., Hui, S. T. Y., Külahçıoğlu, E., Mehrabian, M., Cantor, R. M., Pan, C., Parks, B. W., & Lusis, A. J. (2016) · Journal of Lipid Research · doi:10.1194/jlr.m071522 · Cited by 74
Echeverría, F., Valenzuela, R., Bustamante, A., Álvarez, D., Ortíz, M., Soto-Alarcón, S. A., Muñoz, P., Corbari, A., & Videla, L. A. (2018) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2018/5109503 · Cited by 72
Lee, H., Ahn, J., Shin, S. S., & Yoon, M. (2018) · International Journal of Obesity · doi:10.1038/s41366-018-0212-0 · Cited by 72
Hepatic STAMP2 alleviates high fat diet-induced hepatic steatosis and insulin resistance
Kim, H. Y., Park, S. Y., Lee, M. H., Rho, J. H., Oh, Y. J., Jung, H. U., Yoo, S. H., Jeong, N. Y., Lee, H. J., Suh, S., et al. (2015) · Journal of Hepatology · doi:10.1016/j.jhep.2015.01.025 · Cited by 50
Silybum marianum oil attenuates hepatic steatosis and oxidative stress in high fat diet-fed mice
Zhu, S. Y., Jiang, N., Yang, J., Tu, J., Zhou, Y. H., Xiao, X., & Dong, Y. (2018) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.01.144 · Cited by 48
Tsujimoto, S., Kishina, M., Koda, M., Yamamoto, Y., Tanaka, K., Harada, Y., Yoshida, A., & Hisatome, I. (2016) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2016.2674 · Cited by 44
Kirovski, G., Dorn, C., Huber, H., Moleda, L., Niessen, C., Wobser, H., Schacherer, D., Buechler, C., Wiest, R., & Hellerbrand, C. (2011) · Experimental and Molecular Pathology · doi:10.1016/j.yexmp.2011.08.001 · Cited by 43
Kim, D., Kim, H., Kim, K., & Roh, S. (2017) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2017/8639485 · Cited by 43
Li, H., Yoo, W., Park, H., Lim, S.-Y., Shin, D., Kim, S., Park, H.-Y., & Jeong, T. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20092325 · Cited by 13
Lu, H.-J., Tzeng, T., Liou, S., Chang, C. J., Yang, C. Z., Wu, M., & Liu, I.-M. (2014) · BioMed Research International · doi:10.1155/2014/652680 · Cited by 11
Effects of bixin in high-fat diet-fed-induced fatty liver in C57BL/6J mice
Gutiérrez, R. M. P., & Romero, R. V. (2016) · Asian Pacific Journal of Tropical Biomedicine · doi:10.1016/j.apjtb.2016.09.006 · Cited by 10
Cited by
Gut Microbiota Metabolites in NAFLD Pathogenesis and Therapeutic Implications
Chen, J., & Vitetta, L. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21155214 · Cited by 352
Zeng, X., Li, X., Li, X., Wei, C., Shi, C., Hu, K., Kong, D., Luo, Q., Xu, Y., Shan, W., et al. (2023) · Blood · doi:10.1182/blood.2022017514 · Cited by 157
Metadata
- Authors
- Ji, Y., Gao, Y., Chen, H., Yin, Y., & Zhang, W.
- Venue
- Nutrients
- Publisher
- MDPI AG
- Published
- 2019-09-03
- Volume
- 11
- Issue
- 9
- Pages
- 2062
- ISSN
- 2072-6643 (ISSN-L)
- OpenAlex
- W2972269795
- Cited by
- 288
- References
- 42
- FWCI
- 15.73
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.